期刊文献+

二甲双胍在高海拔地区糖尿病治疗中的安全性研究 被引量:4

Safety of metformin in diabetic patients at high altitude area
原文传递
导出
摘要 高海拔地区初诊糖尿病患者61例,个体化治疗基础上全部加用二甲双胍1.5g/d治疗14 d.平均海拔2 260米和2 780米两地区(海拔差580米),氧分压相差3.5 mm Hg(1 mm Hg=0.133 kPa),初发糖尿病患者在治疗前血乳酸水平即高于正常值.高海拔地区中青年组及老年组治疗前血乳酸水平均较高[(3.90±0.85对3.65±0.70)、(4.67±0.80对3.69±0.78)mmol/L,均P<0.05],中青年组糖尿病患者加用二甲双胍14 d后血乳酸水平未显著上升[(4.50±0.50和3.79±0.62)mmol/L,P>0.05],老年组糖尿病患者加用二甲双胍14 d后血乳酸水平明显上升[(5.59±0.55和5.27±0.43)mmol/L,P<0.05].因此,在高原地区的老年糖尿病患者应慎用或避免使用二甲双胍. Sixty-one newly-diagnosed diabetic patients from high altitude area were treated individually plus metformin 1.5 g/d for 14 days. The difference of oxygen partial pressure was 3.5 mm Hg (1 mm Hg=0. 133kPa) between altitude 2 260 m and 2 780 m districts. In these patients, their serum lactic acid was increased before treatment. At altitude 2 780 m district, serum lactic acid in middle-aged and elder groups were even higher [(3.90±0.85 vs 3.65±0.70), (4. 67±0.80 vs 3.69±0.78) mmol/L, both P〈0. 05=. After 14-day treatment, serum lactic acid in middle-aged diabetic patients remained statistically unchanged [(4.50±0.50 and 3.79±0.62 ) mmol/L, P〉0.05], while that in elder patients was increased significantly [(5.59±0.55 and 5.27±0.43 ) mmol/L,P〈0. 05]. The results suggested that metformin should not be used or be used carefully in elder diabetic patients at high altitude area.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2010年第10期865-867,共3页 Chinese Journal of Endocrinology and Metabolism
基金 青海省科技项目计划基金(2009-Z-724)
关键词 低氧 糖尿病 血乳酸 二甲双胍 Hypoxia Diabetes mellitus Blood lactic acid Metformin
  • 相关文献

参考文献8

二级参考文献15

  • 1陆惠娟,唐峻岭,袁巧英,贾伟平,项坤三.静脉全血乳酸正常参考值的建立[J].上海医学,2005,28(1):27-29. 被引量:6
  • 2肖新华.糖尿病乳酸性酸中毒[J].内科急危重症杂志,2005,11(4):151-153. 被引量:20
  • 3范红旗,郭锡熔.代谢综合征与肥胖[J].医学综述,2007,13(1):71-73. 被引量:3
  • 4Khan JK, Pallaki M, Tolbert SR, et al. Lactic acidemia associated with metformin [ J ]. Ann Pharmacother, 2003,37 ( 1 ) : 66 - 69. 被引量:1
  • 5Rachmani R,Slavachevski I,Levi Z,et al.Metformin in patients with type 2 diabetes mellitus:reconsideration of traditional contraindications[J].Eur J Intern Med,2002,13(7):428-434. 被引量:1
  • 6Orban JC,Giunti C,Levraut J,et al.Metformin-associated lactic acidosis remains a serious complication of mefformin therapy[J].Ann Fr Anesth Reanim,2003,22(5):461-465. 被引量:1
  • 7Salpeter SR,Greyber E,Pasternak GA,et al.Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus:systematic review and mcta-analysis[J].Arch Intern Med,2003,163 (21):2594-2602. 被引量:1
  • 8Abbasi AA,Kasmikha R,Sotingeanu DG.Metformin-induced lactic acidemia in patients with type 2 diabetes mellitus[J].Endocr Pract,2000,6(6):442 -446. 被引量:1
  • 9Khan JK,Pallaki M,Tolbert SR,et al.Lactic acidemia associated with metformin[J].Ann Pharmacother,2003,37 (1):66-69. 被引量:1
  • 10Cunha MR,da Silva ME,Machado HA,et al.The effects of metformin and glibenclamide on glucose metabolism,counter-regulatory hormones and cardiovascular responses in women with type 2 diabetes during exercise of moderate intensity[J].Diabet Med,2007,24(6):592-599. 被引量:1

共引文献63

同被引文献28

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部